Eupraxia Pharmaceuticals Inc.
EPRX
$7.51
-$0.07-0.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 143.38% | 927.03% | -15.23% | -23.54% | 71.14% |
| Total Receivables | 194.54% | 32.11% | -13.27% | 42.64% | 20.09% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 248.92% | 105.00% | 177.97% | 548.19% | 308.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 147.12% | 824.16% | -6.91% | -21.01% | 73.90% |
|
|
|||||
| Total Current Assets | 147.12% | 824.16% | -6.91% | -21.01% | 73.90% |
| Net Property, Plant & Equipment | 132.31% | 86.55% | 54.50% | 31.72% | -6.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.42% | 430.43% | 1,591.30% | 1,332.14% | 1,071.01% |
| Total Assets | 146.55% | 790.98% | -5.52% | -20.21% | 72.42% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 82.93% | 63.18% | 31.20% | -46.12% | -22.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.18% | -3.43% | -99.24% | -99.45% | -99.31% |
| Total Finance Division Other Current Liabilities | 101.93% | 26.01% | -99.43% | -99.11% | -99.59% |
| Total Other Current Liabilities | 101.93% | 26.01% | -99.43% | -99.11% | -99.59% |
| Total Current Liabilities | 81.35% | 60.62% | -77.43% | -88.13% | -83.98% |
|
|
|||||
| Total Current Liabilities | 81.35% | 60.62% | -77.43% | -88.13% | -83.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 560.84% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 83.80% | 63.62% | -77.50% | -88.13% | -83.98% |
|
|
|||||
| Common Stock & APIC | 63.61% | 57.93% | 3.58% | 3.71% | 23.94% |
| Retained Earnings | -29.45% | -23.79% | -24.63% | -23.51% | -24.17% |
| Treasury Stock & Other | 50.87% | -17.94% | 4.51% | -50.51% | -53.72% |
| Total Common Equity | 2,977.38% | 512.62% | -161.69% | -115.87% | -23.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -6.20% | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -6.20% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2,977.38% | 512.62% | -161.69% | -115.87% | -23.31% |
| Total Preferred Equity | -6.20% | -- | -- | -- | -- |
| Total Minority Interest | -1.88% | -2.78% | -5.54% | -9.23% | -18.27% |
| Total Equity | 152.67% | 1,008.61% | 57.28% | 49.30% | 3,468.19% |
|
|
|||||